Clinical Trials Logo

Filter by:
NCT ID: NCT04982666 Withdrawn - Crohn Disease Clinical Trials

Whole-Food, Plant-Based Diet for Active Crohn's Disease

Start date: April 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the ability of a whole-food, plant-based (WFPB) diet to produce symptomatic remission in Crohn's Disease patients.

NCT ID: NCT05152641 Withdrawn - Clinical trials for Acute Posthemorrhagic Anemia

Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery

Start date: April 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to explore the safety and tolerability of BGE-117 and gain information on the effectiveness of different doses when given to patients 65 years or older with moderate to severe anemia following major hip surgery. BGE-117 is given once daily in a capsule by mouth for up to 12 weeks. Patients are also given oral iron supplements. Anemia following surgery has been associated with decreases in patient functioning. This study will measure improvement of anemia, as well as various patient functioning.

NCT ID: NCT05165849 Withdrawn - Solid Tumor Clinical Trials

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Start date: April 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety/tolerability, pharmacokinetics, and efficacy of GFS101A in combination with Toripalimab in patients with advanced solid tumors.

NCT ID: NCT05172349 Withdrawn - Corneal Ulcer Clinical Trials

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers

Start date: April 2022
Phase: Phase 2
Study type: Interventional

The purpose of this open, multicenter pilot trial is to assess the impact of the use of an amniotic membrane on the healing of a persistent epithelial lesion or of a corneal ulcer.

NCT ID: NCT05180149 Withdrawn - Personality Clinical Trials

Personality and Drug Use (PDU)

PDU
Start date: April 2022
Phase:
Study type: Observational

The study aims to assess whether the use of drugs relates to personality ratings. Specifically, we plan to investigate if people with different histories of substance use differentiate on personality assessments (current and past).

NCT ID: NCT05224856 Withdrawn - COVID-19 Clinical Trials

To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen

Start date: April 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3 study to assess the efficacy about therapeutic effect of inhaled CT-P63 and CT-P66 combination therapy to symptomatic patiemts with COVID-19 and overall safety.

NCT ID: NCT05245435 Withdrawn - Prostate Cancer Clinical Trials

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Start date: April 2022
Phase: N/A
Study type: Interventional

Depending on the cohort of the study the diagnostic and prognostic accuracy and health economics considerations of [18F]-fluoro-5α-dihydrotestosterone (FDHT)- positron emission tomography (PET) and/or circulating tumor cells in prostate cancer patients are studied.

NCT ID: NCT05245760 Withdrawn - Esophageal Cancer Clinical Trials

ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer

CRATER
Start date: April 2022
Phase: Phase 2
Study type: Interventional

This study aims to determine the effects of chemoradiation and Tislelizumab on Esophageal/EGJ Cancer before and after surgery.

NCT ID: NCT05255770 Withdrawn - Ejaculation Delayed Clinical Trials

A Clinical Investigation to Assess the Effectiveness of Benzocaine Condoms in Healthy Adult Men

Start date: April 2022
Phase: N/A
Study type: Interventional

This investigation is designed to evaluate the effectiveness of two NRL condoms with Benzocaine paste compared with a standard NRL control.

NCT ID: NCT05256498 Withdrawn - Overactive Bladder Clinical Trials

AURA 1: Augmenting Urinary Reflex Activity: Study 1

AURA1
Start date: April 2022
Phase: N/A
Study type: Interventional

AURA 1 (Augmenting Urinary Reflex Activity: study 1) is a study that evaluates the electrophysiological responses of pudendal nerve stimulation using short-duration extracorporeal stimulation